BRIDGEWATER, N.J., Feb. 24, 2021 /PRNewswire/ -- Insmed Incorporated
(Nasdaq: INSM), a global biopharmaceutical company on a mission to
transform the lives of patients with serious and rare diseases,
today announced that management will participate in the
following virtual investor events:
- The Cowen 41st Annual Health Care Conference on
Wednesday, March 3, 2021 at
11:40 a.m. ET
- The H.C. Wainwright Global Life Sciences Conference on
Tuesday, March 9, 2021 at
7:00 a.m. ET
Each fireside chat will be webcast and can be accessed by
visiting the investor relations section of the Company's website at
www.insmed.com. Each webcast will be archived for a period of 30
days following the conclusion of each live event.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product is a first-in-disease
therapy approved in the United
States and the European Union to treat a chronic,
debilitating lung disease. The Company is also progressing a robust
pipeline of investigational therapies targeting areas of serious
unmet need, including neutrophil-mediated inflammatory diseases and
rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing
footprint across Europe and in
Japan. For more information, visit
www.insmed.com.
Contact:
Investors:
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/insmed-to-present-at-two-march-conferences-301233968.html
SOURCE Insmed Incorporated